SSShintaro Sagami

Shintaro Sagami

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shintaro Sagami has a total of 168 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effectiveness of guselkumab on intestinal ultrasound-based transmural healing in patients with ulcerative colitis (INFINIUS): protocol for a prospective observational study

    by Jun Miyoshi, Shintaro Sagami, Taku Kobayashi, Ayako Sasaki, Hiroaki Tsuchiya, Tomoko Takano, Yoko Takahashi, Yoichi Inoue, Tadakazu Hisamatsu

  • Open Access

    Intestinal Ultrasound in the Diagnostic Assessment of Inflammatory Bowel Disease and Infectious enterocolitis: A Case-Based Narrative Review

    by Shintaro Sagami, Akshay S. Kulkarni, Harshad Joshi, Taku Kobayashi

    Background: Intestinal ultrasound (IUS) provides rapid, noninvasive assessment of transmural inflammation in inflammatory bowel disease (IBD). In clinical practice, infectious enterocolitis frequently mimics IBD activity or complicates established diseases, creating diagnostic uncertainty at presentation and increasing the risk of inappropriate treatment escalation. Summary: This case-based narrative review describes how IUS can support diagnostic assessment in patients with suspected IBD activity or infectious enterocolitis. We summarize core IUS parameters, including bowel wall thickness, mural vascularity, and bowel wall stratification, along with supportive findings, such as perienteric inflammatory fat, lymphadenopathy, and haustral changes. Validated IUS-based approaches for ulcerative colitis (UC) and Crohn’s disease (CD), including the Milan Ultrasound Criteria (MUC), International Bowel Ultrasound Segmental Activity Score (IBUS-SAS), and transperineal ultrasound (TPUS) for rectal assessment, are summarized. Using representative cases, we highlight characteristic pattern-based IUS findings across common causes of infectious enterocolitis and intestinal tuberculosis, focusing on disease distribution, symmetry, perienteric involvement, and short-interval evolution on follow-up examinations. These findings will help refine the differential diagnosis and inform subsequent testing in real-world clinical settings. Key Messages: IUS provides readily available, segment-based information that complements clinical evaluation when differentiating IBD activity from infectious enterocolitis. Pattern recognition on IUS may enhance diagnostic safety and guide subsequent investigations; however, findings should be interpreted in the context of clinical presentation and additional diagnostic modalities.

  • Open Access

    Association Between Bowel Urgency and Intestinal Ultrasound Parameters in Ulcerative Colitis: Insights Into Transmural Inflammation and Symptom Pathophysiology

    by Kanade Serizawa, Shintaro Sagami, Satoko Umeda, Kunio Asonuma, Moeko Komatsu, Shunsuke Shibui, Masa Maeda, Akira Nogami, Ryo Karashima, Masaru Nakano, et al.

    Background: Bowel urgency (BU) is a key symptom of ulcerative colitis (UC), often impairing the quality of life. This study aimed to identify intestinal ultrasound parameters associated with BU, given that UC may also have transmural involvement, and compare these with endoscopic activity and biomarkers. Methods: In this single‐centre prospective study, UC patients undergoing colonoscopy between January 31 and September 27, 2023 were enrolled. Transabdominal and transperineal ultrasound were performed to evaluate bowel wall thickness (BWT), including individual layers (mucosa, submucosa, and muscularis propria), and colour Doppler signal (CDS) in the sigmoid colon and rectum. BU was defined according to the Simple Clinical Colitis Activity Index urgency subscore. Results: Of 59 patients, 33 (56%) reported BU. Compared with those without BU, patients with BU had significantly higher C‐reactive protein, Mayo Endoscopic Subscore (MES), BWT (descending colon, sigmoid colon, rectum), CDS (sigmoid colon, rectum), and submucosal and muscularis propria thickness in the sigmoid colon (all p < 0.05). Mucosal thickness and faecal calprotectin were not significantly different ( p = 0.11 and p = 0.48, respectively). In MES‐adjusted logistic regression, submucosal ( p < 0.01) and muscularis propria ( p = 0.03) thickness remained associated with BU, whereas mucosal thickness did not ( p = 0.97). Receiver operating characteristic analysis showed that sigmoid submucosal thickness had greater diagnostic accuracy than mucosal thickness (AUC 0.77 vs. 0.62, p < 0.05). Conclusions: Sigmoid submucosal thickening was associated with BU and suggests that transmural inflammation may contribute to symptom pathophysiology. Trial Registration: UMIN000050099

  • Open Access

    Evaluating sonographic response and remission in inflammatory bowel disease: aligning intestinal ultrasound assessment with STRIDE-II timelines

    by Ashish R Srinivasan, Shintaro Sagami, Andrew Nguyen, Rebecca L Smith, Abhinav Vasudevan, Stuart A Taylor

    Background and Aims: The diagnostic accuracy of intestinal ultrasound (IUS) is established; however, guidance on the timing and interpretation of sonographic response and remission in inflammatory bowel disease (IBD) remains limited. This review synthesizes current evidence to define expected response and remission kinetics in Crohn’s disease (CD) and ulcerative colitis (UC) across STRIDE-II aligned reassessment timepoints. Methods: A structured narrative review was undertaken of studies published up to August 31, 2025 evaluating longitudinal IUS changes following initiation of medical therapy in patients with CD and UC. Outcomes were synthesized across early (<3 months), intermediate (3-6 months), and longer-term (6-12 months) reassessment intervals aligned with STRIDE-II timelines. Results: In CD, sonographic response was reported in approximately 51%-66% of patients by 12 weeks, while remission was reported in 14%-37%. At 3-6 months, response was reported in approximately 36%-38%, while remission was reported in 12%-38%. Longer-term response and remission were reported in approximately 36%-57% and 24%-42%, respectively, at 48-56 weeks. In UC, response was reported in 57%-77% and remission in 45%-64% by weeks 8-12 in selected cohorts. However, traditional IUS response and remission estimates beyond this early treatment phase remain limited in UC. Direct comparisons between studies was limited by heterogeneity in outcome definitions, reassessment timepoints, therapy class, and disease characteristics. Conclusion: IUS is a practical, non-invasive tool for monitoring therapeutic response in IBD. The optimal timing of reassessment is likely to vary according to therapy-specific time to response, IBD subtype, disease phenotype, and bowel segment. Standardization of definitions and reassessment timelines remain central to integrating IUS into treat-to-target models of IBD care.

  • Open Access

    Exploratory Risk Patterns of Steroid Dependency in Ulcerative Colitis: A Multicenter Pilot Study Combining Logistic Regression and Self-Organizing Map Analysis

    by Yusuke Miyatani, Tetsuro Takayama, Shinji Okabayashi, Toshiyuki Endo, Tomoe Tashiro, Aya Hojo, Kunio Asonuma, Shintaro Sagami, Toshifumi Hibi, Masaru Nakano, et al.

    Introduction: Systemic corticosteroids remain widely used in ulcerative colitis (UC), yet approximately half of initial responders relapse during tapering or soon after discontinuation (steroid dependency). Understanding patients at risk of steroid dependency may inform individualized treatment strategies. Here, we explore factors associated with steroid dependency using conventional regression analysis and an exploratory artificial neural network approach. Methods: Consecutive patients with UC who received their first course of systemic corticosteroids from May 2012 to March 2020 were retrospectively screened, and those who responded to corticosteroids at day 30 were enrolled from four institutions. Factors associated with steroid dependency were assessed by multivariable logistic regression and a self-organizing map (SOM), an unsupervised neural network. Steroid dependency was defined as clinical relapse during tapering or within 3 months after completion of corticosteroids. Results: A total of 107 patients who showed a clinical response at day 30 were analyzed. Thirty-three (30.8%) patients developed steroid dependency. In the multivariable logistic analysis, extensive colitis, initial dose of prednisolone, and two-item patient-reported outcome score at day 30 were independently associated with steroid dependency. In the SOM analysis, patients were categorized into 8 clusters with variable rates of steroid dependency, indicating heterogeneous multidimensional clinical patterns beyond those captured by conventional regression analysis. Conclusion: By combining an unsupervised SOM with conventional logistic regression, our study provided an exploratory visualization of multidimensional clinical patterns associated with steroid dependency. These findings are hypothesis-generating and require prospective validation with a larger sample size before clinical application.

  • Open Access

    Distinct predictive factors for acute severe ulcerative colitis in East Asian and Western populations

    by Eun Soo Kim, Dong Hyun Kim, Seong-Jung Kim, Sang Hyoung Park, Hyun Seok Lee, Sung Kook Kim, Hyun Soo Kim, Jun Lee, Kyeong Ok Kim, Byung Ik Jang, et al.

    Background: This study aimed to develop predictive models for acute severe ulcerative colitis (ASUC) using data from East Asian (EA) patients and to validate their performance in an Australia/New Zealand (ANZ) cohort. Methods: A retrospective international study was conducted across 23 referral hospitals in EA and ANZ, enrolling consecutive ASUC patients between January 2015 and December 2022. Logistic regression analyses were used to construct predictive models for 1-year colectomy and non-response to corticosteroid therapy (NRS). Results: Overall, 826 patients with ASUC were included (411 EA and 415 ANZ). Among EA patients, independent predictors of 1-year colectomy included female sex, prior exposure to tumor necrosis factor inhibitors, and admission albumin ≤3 g/dL. Independent predictors of NRS in the EA cohort were age at diagnosis ≤37 years, baseline steroid use, admission albumin ≤2.5 g/dL, and the presence of extraintestinal manifestations. The EA-derived scoring systems demonstrated strong predictive performance within the EA cohort (1-year colectomy: P < .0001; NRS: P = .001) but showed limited utility in the ANZ cohort (P = .106 and P = .012). In contrast, European-developed models—including the French 1-year colectomy score and the ADMIT-ASC index for NRS—accurately predicted outcomes in the ANZ cohort (P = .007 and P < .0001) but had reduced predictive capacity in the EA cohort (P = .106 and P = .026). These findings were consistent in both cohorts following propensity score matching. Conclusions: Predictive factors for ASUC differ substantially between EA and ANZ patients, highlighting the need for population-specific predictive tools.

  • Open Access

    Utilizing intestinal ultrasound to assess treatment response in ulcerative colitis

    by Shintaro Sagami, Taku Kobayashi

    Utilizing intestinal ultrasound to assess treatment response in ulcerative colitis

  • Open Access

    Expert Position Statement: Defining the Role of Intestinal Ultrasound in Assessing Constipation and Faecal Loading

    by Ryan M. Mathias, Thomas M. Goodsall, Claire E. Parker, Alice S. Day, Yoon K. An, Brandon Baraty, Chamara Basnayake, Jakob Begun, Ray K. Boyapati, Rebecca Burgell, et al.

    Background: Intestinal ultrasound has been proposed as a tool to assess non‐inflammatory functional gastrointestinal disorders, including constipation and faecal loading. However, well‐defined sonographic criteria for these conditions are currently lacking.Aim: To identify and establish specific sonographic parameters that could be used to assess constipation and faecal loading with intestinal ultrasound.Methods: We conducted a Research and Development/University of California Los Angeles appropriateness method exercise. A multidisciplinary, international panel comprising 14 experts in adult and paediatric gastroenterology and one radiologist experienced in gastrointestinal imaging rated the appropriateness of 57 statements using a 9‐point Likert scale over two rounds of voting. Based on the median panel rating and level of disagreement, statements were categorised as appropriate, inappropriate or uncertain.Results: 43 statements were deemed appropriate after two rounds of voting, while three were rated as inappropriate and five as uncertain. Intestinal ultrasound was determined to be an appropriate modality for the assessment of faecal loading. Posterior acoustic shadowing and echogenic reflections were considered important sonographic parameters for the assessment of faecal loading. A rectal diameter of 30 mm was considered appropriate to define faecal loading in paediatric patients, although no recommendation was made for adult patients due to a paucity of data.Conclusion: The expert panel considered intestinal ultrasound an appropriate modality for evaluating constipation and faecal loading. Further prospective research is required, especially in adult patients, to define sonographic metrics of luminal contents to broaden its application in the assessment of functional gastrointestinal disorders.


  • Open Access

    Early resolution of bowel urgency by budesonide foam enema results in improved quality of life in patients with ulcerative colitis: a multicenter prospective observational study

    by Taku Kobayashi, Kei Moriya, Toshimitsu Fujii, Shigeki Bamba, Shinichiro Shinzaki, Akihiro Yamada, Takashi Hisabe, Shintaro Sagami, Shuji Hibiya, Takahiro Amano, et al.

    Background/Aims: Bowel urgency is an important symptom for quality of life determination in patients with ulcerative colitis (UC). Few clinical studies have focused on bowel urgency as an efficacy endpoint. Budesonide foam enema has shown efficacy for clinical and endoscopic improvement in mild-to-moderate UC. We evaluated the improvement of clinical symptoms (bowel urgency), safety, and treatment impact of twice-daily budesonide foam enema on the quality of life in patients with UC.Methods: This open-label, multicenter, prospective observational study comprised a 4-week observation period assessing the effectiveness and safety of twice-daily budesonide foam enema. Mild-to-moderate UC patients who had bowel urgency were included. Patients collected data daily in an electronic patient-reported outcome system or logbooks. The primary endpoint was the rate of resolution of bowel urgency at the end of the 4-week observation period. The rate of bowel incontinence was also assessed. Results: Sixty-one patients were enrolled. Of patients with a final evaluation, the rate of resolution of bowel urgency was 58.5% (31/53; 95% confidence interval, 44.1%–71.9%). Bowel urgency decreased over time, with a significant difference observed on day 7 versus day 0. Bowel incontinence showed a decreasing trend from day 5, with a significant difference confirmed on day 12 versus day 0. The clinical remission rate was 64.4% (38/59; 95% confidence interval, 50.9%–76.4%). One adverse event not related to budesonide rectal foam occurred. Conclusions: The findings suggest that bowel urgency can be improved early with twice-daily budesonide foam enema. No new safety signals were observed.